Company intelligence / Profile preview

DocMed Technology

Ownership: Private
Development stage: Commercial

Overview

DocMed Technology is Singapore’s largest B2B online pharma marketplace and the first HSA-approved e-pharma for direct patient delivery. It provides digital solutions for healthcare practitioners across ASEAN, including an extensive product catalog (>5,000 SKUs), rapid home medication delivery via WellAway e-pharmacy, and data-driven tools for care coordination through its platforms. The company serves over 85% of clinics/pharmacies in Singapore and has expanded into Malaysia, Indonesia, Vietnam, and the Philippines.

Modalities: Not directly developing therapeutics; operates as a digital health and pharmaceutical distribution platform. No direct drug R&D.
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

major local distributors (for regional expansion)

Beyond the preview

Go deeper on DocMed Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DocMed Technology.

Explore the full profile